ConductScience.org, home

Paper40540751

Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors.

Andricovich J and 2 others. Blood, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors. Papers, record 40540751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40540751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors.
PubMed
Journal
Blood
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.07, provisional
iCite
Revised in PubMed
2026-10-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Andricovich JJaclynhttps://orcid.org/0000-0003-2945-5095
2Lap CJCoen Johanneshttps://orcid.org/0000-0001-6815-0695
3Tzatsos AAlexandroshttps://orcid.org/0000-0002-8476-4328

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ubiquitin ThiolesteraseMajor topic
Leukemia, Myeloid, AcuteMajor topic
Tumor Suppressor Protein p53Major topic
Tumor Suppressor ProteinsMajor topic
MutationMajor topic
Animals
Humans
Mice
Mice, Knockout
Gene Expression Regulation, Leukemic

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA222930NCI NIH HHSUnited StatesR01CA222930PubMed

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in40965944BAP1/TP53 loss defines a BCL-xL-dependent erythroleukemia.https://conductscience.org/library/papers/40965944

Source PubMed

Download CSV of comments and corrections

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135688146Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq.Cell2022https://conductscience.org/library/papers/35688146PubMed
238458202H2AK119ub1 differentially fine-tunes gene expression by modulating canonical PRC1- and H1-dependent chromatin compaction.Mol Cell2024https://conductscience.org/library/papers/38458202PubMed
310783170Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.Genes Dev2000https://conductscience.org/library/papers/10783170PubMed
429113963Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies.Blood2018https://conductscience.org/library/papers/29113963PubMed
589763893p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia.Cytogenet Cell Genet1996https://conductscience.org/library/papers/8976389PubMed
623827712SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors.Cell Stem Cell2013https://conductscience.org/library/papers/23827712PubMed
735868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022https://conductscience.org/library/papers/35868306PubMed
822878500Loss of the tumor suppressor BAP1 causes myeloid transformation.Science2012https://conductscience.org/library/papers/22878500PubMed
98329702Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7.Blood1993https://conductscience.org/library/papers/8329702PubMed
1026437366Loss of BAP1 function leads to EZH2-dependent transformation.Nat Med2015https://conductscience.org/library/papers/26437366PubMed
111552940Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.Nature1992https://conductscience.org/library/papers/1552940PubMed
1238849395ASXLs binding to the PHD2/3 fingers of MLL4 provides a mechanism for the recruitment of BAP1 to active enhancers.Nat Commun2024https://conductscience.org/library/papers/38849395PubMed
1325313317Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity.ACS Med Chem Lett2014https://conductscience.org/library/papers/25313317PubMed
1433888563BAP1 constrains pervasive H2AK119ub1 to control the transcriptional potential of the genome.Genes Dev2021https://conductscience.org/library/papers/33888563PubMed
1535732831The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.Leukemia2022https://conductscience.org/library/papers/35732831PubMed
1629622463Genomic and Functional Approaches to Understanding Cancer Aneuploidy.Cancer Cell2018https://conductscience.org/library/papers/29622463PubMed
1718371378Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.Cell Stem Cell2007https://conductscience.org/library/papers/18371378PubMed
1835273156Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data.Nat Commun2022https://conductscience.org/library/papers/35273156PubMed
1924894717Germline mutations in BAP1 impair its function in DNA double-strand break repair.Cancer Res2014https://conductscience.org/library/papers/24894717PubMed
2030472158IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.Cell Stem Cell2019https://conductscience.org/library/papers/30472158PubMed

See all 82 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42499709Tumor suppressor BAP1 emerges as a key regulator of metabolism and cell death in tumors.Front Cell Dev Biol2026https://conductscience.org/library/papers/42499709PubMed
42295372BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia.Cancer Immunol Immunother2026https://conductscience.org/library/papers/42295372PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BAP18314PubTator's text mininghttps://conductscience.org/library/genes/8314NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40540751

GET https://conductscience.org/api/papers/v1/40540751/references?page=2